|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,088.00 DKK | +4.50% |
|
-2.70% | +3.01% |
| 21/01 | DNB Carnegie Upgrades Genmab to Buy, Raises PT | MT |
| 21/01 | Genmab Posts Higher Darzalex Net Sales in FY25 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | +4.50% | -2.70% | +3.01% | +38.28% | -21.97% | 1.93TCr |  |  | |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition